🇬🇧 PF-06700841 45 mg in United Kingdom

PF-06700841 45 mg (pf-06700841-45-mg) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: approved

PF-06700841 45 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United Kingdom

Frequently asked questions

Is PF-06700841 45 mg approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for PF-06700841 45 mg in United Kingdom?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.